Most breast cancers start in the milk ducts or the milk-making lobules, and they fall into a few well-known groups. But a small number of breast cancers start in other cells, or behave in unusual ways, and these very rare types can be confusing to read about. This plain-English roundup explains what “very rare breast cancer types” means, introduces the main types doctors see, and covers how diagnosis, treatment planning, and everyday life tend to work when the cancer is uncommon.
Key Takeaways
- Very rare breast cancers are real but uncommon diagnoses, and most begin in cells other than the usual duct or lobule lining.
- Types covered here include adenoid cystic, apocrine, metaplastic, secretory, and neuroendocrine carcinomas, along with primary breast lymphoma and invasive micropapillary carcinoma.
- Diagnosis usually requires a biopsy, and a second pathology review by an experienced pathologist is common and sensible for rare types.
- Treatment planning is highly individual, and many people benefit from a second opinion at a center that treats their specific type regularly.
- Support communities and a well-organized records folder matter even more when the diagnosis is rare.
What “Very Rare” Means in Breast Cancer
When doctors talk about common breast cancers, they usually mean invasive ductal carcinoma and invasive lobular carcinoma, which together account for the great majority of cases. A “very rare” type is one that makes up only a small fraction of breast cancer diagnoses. If you want exact figures, the American Cancer Society (cancer.org) and the National Cancer Institute (cancer.gov) publish current numbers.
Rare does not mean mysterious. Each rare type has a known starting cell and a known pattern of growth. The challenge is practical: fewer doctors see these cancers often, and online information can be thin or outdated. That is why the rest of this guide emphasizes how to get the right expert eyes on your case.
It also helps to keep perspective. For a clear picture of where the rare types sit among all the types, see our overview of how the types of breast cancer compare. The common types share a lot of features with the rare ones, so much of what you learn about breast cancer in general still applies to you.
Rare Types Covered in This Guide
The types below are the ones readers most often ask about after receiving a biopsy result they have never heard of.
Adenoid cystic carcinoma
This type starts in the duct cells and gets its name from the pattern the cells form under the microscope. It can grow slowly, and it is sometimes found as a lump that has been present for a while. Our fuller guide is adenoid cystic carcinoma of the breast explained.
Apocrine carcinoma
Apocrine cells are a kind of cell found in the breast’s ducts and glands, and they can also turn cancerous. This type is identified by how the cells look under the microscope, with abundant pinkish cytoplasm being a classic feature. More detail is in apocrine breast cancer explained.
Metaplastic carcinoma
In metaplastic carcinoma, some of the cancer cells have changed into a different kind of cell, such as skin-like or bone-like cells. This mixed character can make the biopsy harder to interpret, which is one reason expert pathology review matters.
Secretory carcinoma
Secretory carcinoma gets its name from fluid the cancer cells produce, which can be seen under the microscope. It was once thought to occur mainly in younger patients, but it can occur at any age. It tends to be slow-growing, and the treatment plan is tailored to the individual situation.
Neuroendocrine carcinoma
This type starts in cells that have features of both nerve cells and hormone-producing cells. Neuroendocrine tumors are better known in other parts of the body, and when they occur in the breast they are handled by teams familiar with both breast cancer and neuroendocrine tumors.
Primary breast lymphoma
Lymphoma is a cancer of the lymph system, and when it starts in the breast itself rather than spreading there from elsewhere, it is called primary breast lymphoma. It is treated with lymphoma treatments rather than the treatments used for cancers that start in breast tissue, so getting the diagnosis right changes the whole plan.
Invasive micropapillary carcinoma
This type is named for the small, finger-like clusters of cells seen under the microscope. It often has a pattern of spreading to nearby lymph nodes, so the lymph node evaluation is a central part of planning. It can also occur mixed with more common ductal cancer.
Rare Types at a Glance
The table below gives a quick comparison of the types covered above. It is simplified on purpose.
| Type | Where it starts | What doctors tend to note |
|---|---|---|
| Adenoid cystic carcinoma | Duct cells | Often slow-growing; identified by its pattern under the microscope |
| Apocrine carcinoma | Duct and gland cells | Distinct cell appearance; special lab testing may follow |
| Metaplastic carcinoma | Duct cells that changed form | Mixed cell types; can grow quickly; expert pathology review important |
| Secretory carcinoma | Duct cells | Often slow-growing; can occur at any age |
| Neuroendocrine carcinoma | Neuroendocrine-type cells | Benefits from a team familiar with neuroendocrine tumors |
| Primary breast lymphoma | Lymph tissue in the breast | Treated as lymphoma, not as a breast tissue cancer |
| Invasive micropapillary carcinoma | Duct cells | Lymph node evaluation is a key part of planning |
Why a Rare Diagnosis Deserves Extra Care
A rare cancer deserves the same careful treatment as a common one, but getting there takes a few extra steps. The most important one is pathology review. A pathologist is the doctor who studies your biopsy tissue under the microscope, and for a rare type, having that tissue reviewed by a pathologist who has seen many such cases can confirm the diagnosis or catch a subtle detail. Ask your doctor whether your biopsy slides are being reviewed by someone with experience in your specific type.
The second step is the second opinion. With common cancers, many doctors can plan treatment confidently from the standard approach. With a rare type, a doctor who treats it regularly may know about practical options your local team sees less often, and a consultation can produce a written treatment recommendation your local team can follow. Many oncologists expect and welcome second opinions for rare cancers.
Finally, expect the plan to be individual. With rare types, there is less standard guidance than with common cancers, so treatment decisions lean more heavily on the exact type, the stage, your overall health, and your preferences.
How These Cancers Are Diagnosed
Diagnosis follows the same path as for any breast lump. Your doctor performs a physical exam, imaging usually follows, often a mammogram and an ultrasound, and then a biopsy takes a sample of the tissue.
The most common biopsy method is a core needle biopsy, where a hollow needle removes small pieces of tissue. In some cases a surgical biopsy removes part or all of the lump. The tissue goes to the pathology lab, where it is examined under a microscope and tested for features that guide treatment choices.
For a rare type, the lab may do additional testing to confirm exactly which cells are present. This can take a little longer than a standard biopsy result. If you are waiting, it helps to know that a careful, complete pathology report is worth the wait, because the whole treatment plan rests on it.
Once the diagnosis is confirmed, further tests determine the stage, which describes the size of the cancer and whether it has spread. Staging may include imaging of other areas of the body. The stage and the exact type together shape the treatment discussion with your team.
Treatment in General Terms
Treatment for rare breast cancers draws from the same main tools used for other breast cancers, combined in ways that fit the specific type. Surgery to remove the cancer is a common starting point.
Radiation therapy, which uses high-energy rays aimed at the area, may be recommended to lower the chance of the cancer returning in the same area. Chemotherapy, medicine that travels through the bloodstream, may be discussed depending on the type and stage.
Whether hormone therapy or targeted therapy has a role depends on what the lab tests show. These medicines work when the cancer’s cells carry certain features, and not all rare types do.
For primary breast lymphoma, the plan looks different: because it is a lymphoma, treatment follows lymphoma approaches rather than the surgery-first pattern of most breast cancers. This is a clear example of why the exact diagnosis matters so much.
Individual cases differ, so no article can say which combination is right for you. Bring your pathology report to every consultation, and ask each doctor to explain how your specific type shapes their recommendation.
Living With a Rare Diagnosis
A rare diagnosis can feel isolating. Friends and family may never have heard of your type, and even general breast cancer support groups may not have another member with it. Look for communities focused on your specific type, alongside broader breast cancer groups where the treatment experience and the emotions are shared.
Keep your records organized from the start. A simple folder with your pathology report, imaging reports, treatment plan, and your doctors’ contact details pays off quickly, because care for a rare cancer can involve more offices and referrals than usual.
Give yourself permission to ask for plain language. Medical teams sometimes slip into jargon without noticing, and this happens more with rare types that have long, unfamiliar names.
It also helps to pace your research. Reliable, up-to-date information about rare types is best found at the American Cancer Society at cancer.org and the National Cancer Institute at cancer.gov. Random search results about rare cancers can be old or incomplete.
What to Do Next
If you or a loved one has just received one of these diagnoses, these steps can bring order to the first weeks:
- Get a copy of your full pathology report and keep it with your records.
- Ask whether the biopsy tissue is being reviewed by a pathologist experienced with your specific type.
- Schedule a second opinion at a center that treats your type regularly, even if you plan to stay with your local team.
- Write down your questions before each appointment, and bring someone with you when you can.
- Ask your team which reliable sources they recommend for your specific type, so your reading stays grounded.
- Connect with a support community, for your specific type if one exists, or a general breast cancer community.
- Talk with your own doctor or care team about your situation before making any treatment decisions.
Frequently Asked Questions
Is a rare breast cancer harder to treat?
Not necessarily. Some rare types are slow-growing, and the main challenge is often getting the exact diagnosis right and finding a team experienced with it. Once the type is confirmed, treatment follows a plan tailored to it, just as with common cancers.
Should I travel to a specialized center?
It depends on your situation, but at least a consultation is often worthwhile. A center that treats your specific type regularly can review your pathology and suggest a plan, which your local team may then be able to carry out. Ask your doctor for a referral.
Why is my pathology report taking so long?
Rare types often need extra lab testing to confirm the exact cell type, and the tissue may be sent for review by an expert pathologist. A complete, accurate report matters more than a fast one, because treatment is built on it.
Can a rare breast cancer be hereditary?
Most breast cancers, rare or common, are not inherited. But if several people in your family have had breast cancer or related cancers, especially at younger ages, ask your doctor whether genetic counseling could be useful for you.
Where can I find other people with my type?
General breast cancer support organizations can be a starting point, and some have subgroups or can point you toward type-specific communities. Your care team or a hospital social worker may also know of groups for your specific diagnosis.
How do I know if online information about my type is reliable?
Check the source and the date. Major cancer organizations such as the American Cancer Society at cancer.org and the National Cancer Institute at cancer.gov keep their information reviewed and current. Be cautious with old forum posts and sites that sell products alongside medical claims.
Related Articles
- How the types of breast cancer compare, side by side
- Breast sarcoma: what it is and how it differs
- Metaplastic breast cancer explained
- Neuroendocrine breast cancer explained
- Secretory carcinoma of the breast explained
This article is for general educational purposes only and is not medical, legal, or financial advice. It does not replace professional care. Talk to your doctor or care team about your own situation. If you think you may have a medical emergency, call 911.